Presentation/ Webcast
Latest Presentation
FY2021
- Jan. 31, 2022 Q3 FY2021 Conference Call (PDF/1,158KB)
- Jan. 31, 2022 Q3 FY2021 Conference Call (Webcast, available for 12 months)
- Jan. 31, 2022 Q3 FY2021 Conference Call transcript (PDF/10,332KB)
- Oct. 28, 2021 Investors Meeting Presentation for Q2 FY2021 (PDF/1,252KB)
- Oct. 28, 2021 Investors Meeting Presentation for Q2 FY2021 (Webcast, available for 12 months)
- Oct. 28, 2021 Investors Meeting Presentation for Q2 FY2021 transcript (PDF/2,389KB)
- Jul. 29, 2021 Q1 FY2021 Conference Call (PDF/972KB)
- Jul. 29, 2021 Q1 FY2021 Conference Call (Webcast, available for 12 months)
- Jul. 29, 2021 Q1 FY2021 Conference Call transcript (PDF/746KB)
ESG Meeting (2021)
Frontier Business Meeting - FBO Showcase -
Sumitovant Meeting
FY2020
- May 13, 2021 Investors Meeting Presentation for FY2020 (Year ended March 31, 2021) and Revision of Mid-term Business Plan 2022 (PDF/2,290KB)
- May 13, 2021 Investors Meeting for FY2020 and Revision of Mid-term Business Plan 2022 transcript (PDF/4,491KB)
- Jan. 28, 2021 Q3 FY2020 Conference Call (PDF/937KB)
- Oct. 29, 2020 Investors Meeting Presentation for Q2 FY2020 (PDF/1,170KB)
- Jul. 30, 2020 Q1 FY2020 Conference Call (PDF/1,044KB)
ESG Meeting (2020)
FY2019
- May 14, 2020 Investors Meeting Presentation for FY2019(PDF/1,658KB)
- Jan. 30, 2020 Q3 FY2019 Conference Call(PDF/1,387KB)
- Nov. 01, 2019 Investors Meeting Presentation for Q2 FY2019 (April 1 to September 30, 2019) / Definitive Agreement for Strategic Alliance with Roivant Sciences(PDF/1,705KB)
- Sep. 06, 2019 Memorandum of Understanding for Strategic Alliance with Roivant Sciences (PDF/477KB)
- Jul. 29, 2019 Q1 FY2019 Conference Call(PDF/582KB)
R&D Meeting (2020)
ESG Meeting (2019)
Mid-term Business Plan 2022 Presentation
FY2018
- May 13, 2019 Investors Meeting Presentation for FY2018 (PDF/608KB)
- Jan. 31, 2019 Q3 FY2018 Conference Call(PDF/591KB)
- Nov. 20, 2018 ESG Meeting (Discussion with Investors)(PDF/2,067KB)
- Nov. 20, 2018 Q&A Session at the ESG Meeting (Discussion with Investors)(PDF/121KB)
- Oct. 31, 2018 Investors Meeting Presentation for Q2 FY2018(PDF/739KB)
- Jul. 27, 2018 Q1 FY2018 Conference Call(PDF/669KB)
FY2017
FY2016
- Financial Results for FY2016 (May 12, 2017)(PDF/1,390KB)
- R&D Meeting (February 28, 2017)(PDF/3,865KB)
- Third Quarter Financial Results for FY2016 (January 27, 2017)(PDF/1,221KB)
- Acquisition of Tolero Pharmaceuticals, Inc. (December 21, 2016)(PDF/682KB)
- Second Quarter Financial Results for FY2016 (October 27, 2016)(PDF/1,120KB)
- First Quarter Financial Results for FY2016 (July 27, 2016)(PDF/844KB)
FY2015
- Financial Results for FY2015 (May 12, 2016)(PDF/1,176KB)
- Third Quarter Financial Results for FY2015 (January 27, 2016)(PDF/1,385KB)
- R&D Meeting (December 9, 2015)(PDF/4,424KB)
Replaced slides of the R&D meeting presentation material as of December 9th (Revised: deleted the images of CT-scan on the slide 63 and 64)
- Second Quarter Financial Results for FY2015 (October 29, 2015)(PDF/1,011KB)
- First Quarter Financial Results for FY2015 (July 29, 2015)(PDF/562KB)
FY2014
FY2013
- Financial Results for FY2013 (May 9, 2014)(PDF/748KB)
- R&D Meeting (March 5, 2014)(PDF/1,563KB)
- Third Quarter Financial Results for FY2013 (January 31, 2014)(PDF/594KB)
- Second Quarter Financial Results for FY2013 (October 31, 2013)(PDF/1,008KB)
- First Quarter Financial Results for FY2013 (July 31, 2013)(PDF/366KB)
Third Mid-term Business Plan Presentation
FY2012
FY2011
- Financial Results for FY2011 (May 11, 2012)(PDF/679KB)
- Acquisition of Boston Biomedical Inc. (February 29, 2012)(PDF/378KB)
- Third Quarter Financial Results for FY2011 (February 3, 2012)(PDF/204KB)
- J.P.Morgan Healthcare Conference 2012 (January 9, 2012 San Francisco)(PDF/1,333KB)
- Second Quarter Financial Results for FY2011 (November 1, 2011)(Webcast Version)(PDF/186KB)
- First Quarter Financial Results for FY2011 (July 29, 2011)(PDF/186KB)
FY2010
- Financial Results for FY2010 (May 12, 2011)(PDF/436KB)
- Third Quarter Financial Results for FY2010 (Apr. 1 to Dec. 31, 2010) (February 3, 2011)(PDF/223KB)
- LATUDA® Meeting (January 25, 2011), Clinical Development Update(PDF/428KB)
- LATUDA® Meeting (January 25, 2011), Commercial Update(PDF/374KB)
- J.P.Morgan Healthcare Conference 2011 (January 11, 2011 San Francisco)(PDF/577KB)
- Second Quarter Financial Results for FY2010 (Apr. 1 to Sep. 30, 2010) (November 2, 2010)(PDF/360KB)
- At the press conference, Second Quarter Financial Results for FY2010 (Apr. 1 to Sep. 30, 2010) (October 29, 2010)(PDF/403KB)
- First Quarter Financial Results for FY2010 (July 30, 2010)(PDF/344KB)
FY2009
- Financial Results for FY2009 (May 11, 2010)(PDF/323KB)
- Second Mid-term Business Plan -FY2010 to FY2014- (Feb. 16, 2010)(PDF/812KB)
- Third Quarter Financial Results for FY2009 (February 3, 2010)(PDF/266KB)
- Sepracor Inc. Company Overview -November 12, 2009(PDF/957KB)
- (Reference) Sepracor Factbook 2009(PDF/950KB)
- Second Quarter Financial Results for FY2009 (October 29, 2009)(PDF/234KB)
- Acquisition of Sepracor Inc. (September 3, 2009)(PDF/315KB)
- First Quarter Financial Results for FY2009 (July 31, 2009)(PDF/220KB)
- Lurasidone Meeting (June 12, 2009)(PDF/1,177KB)
FY2008
FY2007
FY2006
- Financial Results for FY2006 (May 11, 2007)(PDF/281KB)
- R&D Meeting (March 28, 2007) (PDF/1,270KB)
- FY'07-'09 Mid-term Business Plan (Feb. 28, 2007)(PDF/584KB)
- Consolidated Financial Results for 3rd Quarter of FY2006 (Feb. 2, 2007)(PDF/284KB)
- First Half Financial Results for FY2006 (Nov. 9, 2006)(PDF/341KB)
- R&D Strategy for diabetes (Nov. 9, 2006)(PDF/249KB)
- Financial Results for the First Quarter of FY2006 (July 28, 2006)(PDF/209KB)